Dr. Scott Rocklage has been the managing partner of 5AM Ventures since he took the role back in 2004. Initially, he joined the firm as a venture partner in 2003. Scott Rocklage boasts over 30 years in the healthcare management industry in addition to an extensive scientific background.

His leadership and organizational skills played a significant role in three new drug applications, which are Teslascan, Omniscan, and Cubicin. Consequently, Scott obtained FDA approval.

Early Career

Before he joined 5AM, Dr. Rocklage had been the chairman and CEO of Cubist Pharmaceuticals and had played the same roles at Nycomed Salutar. During his time at Salutar and Catalytica, Scott held some Research and Design posts.

Other positions that Scott Rocklage has held in his long and distinguished career include Vice President and Executive Chairman at Ilypsa Inc. and President and Chief Executive Officer at Amersham Health. He was also the Chairman at Novra Therapeutics Incorporated and Chairman of Cidara Therapeutics’ board.

Educational Background

Dr. Scott Rocklage has an extensive educational background. He earned a Bachelor of Science degree (BS) in Chemistry from the University of California, Berkley as well as a Ph.D. in Chemistry from the Massachusetts Institute of Technology (MIT). They are two of the leading scientific training institutions in the world.

During his time at MIT, Scott was involved in research alongside Richard Schrock, who won the Nobel Prize in Chemistry in 2005. He has also invented or co-invented over 30 patents in the U.S. Scott is the author of more than 100 peer-reviewed scientific publications.

His Achievements with 5AM Ventures

Thanks to the leadership of Dr. Scott Rocklage, 5AM Ventures has grown into a leading venture capital firms that focus on life science companies developing next generation pharmaceutical and medical technologies.

5AM Ventures seeks to support entities involved in the development of solutions that solve the world’s healthcare needs through cutting-edge science. The companies that 5AM supports are at the forefront of the development of unique approaches to the diagnosis, prevention, and treatment of a range of challenging medical conditions.

Due to his educational background and professional experience in the fields of science, strategic leadership and healthcare, he is a highly effective strategist and a leader in pharmaceuticals, venture capital, and health care.

Read more:

Scott Racklage | Bloomberg

Scott Racklage | Crunchbase